Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests - Summary Of Non-controlling Interests in Consolidated Entities (Detail)

v3.3.0.814
Non-Controlling Interests - Summary Of Non-controlling Interests in Consolidated Entities (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Noncontrolling Interest [Line Items]          
NCI equity share     $ 3,726    
Net loss attributed to non-controlling interest $ (1,694) $ 0 (2,416) $ 0  
Non-controlling in consolidated entities 1,310   1,310   $ 0
Avenue [Member]          
Noncontrolling Interest [Line Items]          
NCI equity share     4    
Net loss attributed to non-controlling interest (367)   (401)    
Non-controlling in consolidated entities (397)   (397)    
Coronado SO Co, Inc [Member]          
Noncontrolling Interest [Line Items]          
NCI equity share     23    
Net loss attributed to non-controlling interest (7)   (237)    
Non-controlling in consolidated entities (214)   (214)    
Mustang Therapeutics, Inc [Member]          
Noncontrolling Interest [Line Items]          
NCI equity share     15    
Net loss attributed to non-controlling interest (54)   (321)    
Non-controlling in consolidated entities (306)   (306)    
Checkpoint Therapeutics, Inc [Member]          
Noncontrolling Interest [Line Items]          
NCI equity share     4,076    
Net loss attributed to non-controlling interest (977)   (1,168)    
Non-controlling in consolidated entities 2,908   2,908    
JMC [Member]          
Noncontrolling Interest [Line Items]          
NCI equity share     (392)    
Net loss attributed to non-controlling interest (289)   (289)    
Non-controlling in consolidated entities $ (681)   $ (681)